Data spanning the past 90 days through December 12, 2025 reveals that Edgewise Therapeutics's three principal insider shareholders consist of TenPercentOwner Holdings A/S Novo (6.07Mn shares), Director Peter A. Thompson (443.79K shares), Director Jonathan C Fox (23.70K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Holdings A/S Novo | 6,071,703 | 16 Sep, 2022 | |
| James E Flynn | 3,933,137 | 30 Mar, 2021 | |
| Biomedical Innovation Master Investors (Cayman) I L.P. Wellington | 681,812 | 30 Mar, 2021 | |
| Advisors Llc Orbimed | 443,792 | 04 Apr, 2025 | |
| Peter A. Thompson | 443,792 | 04 Apr, 2025 | |
| R Michael Carruthers | Chief Financial Officer | 86,162 | 14 Aug, 2025 |
| Kevin Koch | President And CEO | 30,615 | 14 Aug, 2025 |
| Joanne M. Donovan | Cmo | 25,361 | 14 Aug, 2025 |
| Jonathan C Fox | 23,702 | 13 Nov, 2025 | |
| Behrad Derakhshan | Chief Business Officer | 23,645 | 14 Aug, 2025 |
| Alan J Russell | Chief Scientific Officer | 23,400 | 13 Nov, 2025 |
| Jonathan D Root | 15,625 | 31 Mar, 2021 | |
| John R Moore | General Counsel | 10,214 | 14 Aug, 2025 |
| Marc Semigran | Chief Development Officer | 6,716 | 27 Dec, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Nov, 2025 | Alan J Russell | Common Stock | A | 100,000 | $0.18 | 123,400 | D | M |
| 12 Nov, 2025 | Alan J Russell | Common Stock | D | 100,000 | $21.12 | 23,400 | D | S |
| 11 Nov, 2025 | Jonathan C Fox | Common Stock | A | 10,700 | $18.64 | 23,702 | D | P |
| 01 Oct, 2025 | Jonathan C Fox | Common Stock | A | 728 | $0.00 | 13,002 | D | A |
| 26 Aug, 2025 | Alan J Russell | Common Stock | A | 100,000 | $0.18 | 123,400 | D | M |
| 26 Aug, 2025 | Alan J Russell | Common Stock | D | 100,000 | $14.60 | 23,400 | D | S |
| 12 Aug, 2025 | Alan J Russell | Common Stock | A | 5,781 | $0.00 | 25,307 | D | M |
| 12 Aug, 2025 | John R Moore | Common Stock | A | 5,781 | $0.00 | 12,312 | D | M |
| 12 Aug, 2025 | Kevin Koch | Common Stock | A | 17,968 | $0.00 | 38,587 | D | M |
| 12 Aug, 2025 | Joanne M. Donovan | Common Stock | A | 5,781 | $0.00 | 28,223 | D | M |
| 12 Aug, 2025 | Behrad Derakhshan | Common Stock | A | 5,781 | $0.00 | 26,136 | D | M |
| 12 Aug, 2025 | Kevin Koch | - | - | 38,587 | D | |||
| 12 Aug, 2025 | R Michael Carruthers | Common Stock | A | 5,781 | $0.00 | 87,590 | D | M |
| 12 Aug, 2025 | Alan J Russell | Common Stock | D | 1,907 | $13.39 | 23,400 | D | S |
| 12 Aug, 2025 | John R Moore | Common Stock | D | 2,098 | $13.39 | 10,214 | D | S |
| 12 Aug, 2025 | Behrad Derakhshan | Common Stock | D | 2,491 | $13.39 | 23,645 | D | S |
| 12 Aug, 2025 | Kevin Koch | Common Stock | D | 7,972 | $13.39 | 30,615 | D | S |
| 12 Aug, 2025 | Joanne M. Donovan | Common Stock | D | 2,862 | $13.39 | 25,361 | D | S |
| 12 Aug, 2025 | R Michael Carruthers | Common Stock | D | 1,428 | $13.39 | 86,162 | D | S |
| 12 Aug, 2025 | John R Moore | - | - | 10,214 | D |